How Direct 3D Printing is Disrupting Europe's Orthodontic Market

SEOUL, South Korea – November 11, 2026

For decades, the orthodontic industry has been defined by slow, incremental shifts. The transition from traditional metal brackets to clear, thermoformed plastic aligners revolutionized patient aesthetics and comfort, creating a multi-billion-dollar global market dominated by a handful of corporate giants. Yet, behind the scenes, the manufacturing process for these clear aligners has remained surprisingly archaic, relying on labor-intensive thermoforming techniques where plastic sheets are heated and vacuum-sealed over physical dental molds.

Now, a fundamental disruption is underway, driven by the convergence of advanced materials science and localized digital manufacturing. Graphy Inc., a Seoul-based developer of advanced photopolymers, recently announced that it has completed the final conformity assessment review under the European Union's Medical Device Regulation (EU MDR) for five of its core dental 3D printing materials. Currently awaiting formal certificate issuance, the company is poised to introduce its direct 3D-printed Shape Memory Aligners (SMA) to the European market at scale.

This regulatory milestone is more than a corporate victory for a South Korean materials manufacturer; it represents a critical inflection point in how dental care will be produced, distributed, and experienced across Europe. By eliminating the need for physical molds and thermoforming, direct 3D printing promises to decentralize production, empower local dental laboratories, and fundamentally alter the biomechanics of orthodontic treatment.

Navigating Fortress Europe's Regulatory Labyrinth

To understand the significance of Graphy's recent announcement, one must first understand the formidable barrier to entry that is the EU MDR. Implemented to replace the older Medical Devices Directive (MDD), the Regulation (EU) 2017/745 introduced a notoriously strict framework designed to prioritize patient safety. It demands exhaustive clinical evidence, rigorous technical documentation, robust quality management systems, and stringent post-market surveillance.

The transition to the MDR has been so demanding that numerous medical device manufacturers have opted to withdraw legacy products from the European market rather than shoulder the immense compliance costs. For a non-European company to successfully navigate this labyrinth with a novel, Class IIa-equivalent material is a testament to the underlying science and quality control of the product.

"Completing the final CE-MDR review is significant because five of our core dental 3D printing materials have passed the rigorous assessment process under the EU's strengthened medical device requirements," said Un seob Sim, Chairman of Graphy. "Once the certificates are issued, we will expand our local manufacturing and distribution partnerships in Europe and translate our proprietary materials technology into tangible orders and revenue."

The cleared products include three materials from the TeraHarz Clear series (TC-85DAC, TA-28, TR-07) and two from the TeraHarz series (TC-80DC, BR-23). By securing this clearance—building upon previous U.S. FDA 510(k) and Brazilian ANVISA registrations—the materials developer has effectively de-risked its technology for European partners, removing the primary bottleneck to continental adoption.

The Technological Leap: Aligner 4.0

The true innovation at the heart of this regulatory triumph lies in the material itself. Traditional clear aligners are manufactured by 3D printing a model of the patient's teeth, heating a thermoplastic sheet, and vacuum-forming it over the model. This process inherently leads to uneven thickness; the plastic stretches and thins out over the cusps of the teeth, precisely where consistent force is most needed. Furthermore, traditional thermoplastics tend to lose their elasticity at body temperature, leading to a rapid degradation of the orthodontic force applied to the teeth within days of insertion.

Graphy's approach, often dubbed "Aligner 4.0" by industry insiders, bypasses the physical mold entirely. Using proprietary photocurable resins like the TeraHarz TC-85DAC, aligners are 3D printed directly from digital design files.

This direct printing method allows for uniform thickness across the entire appliance, resulting in a more precise fit and superior "tracking"—the industry term for how accurately the aligner moves the teeth according to the treatment plan. More importantly, the TeraHarz materials possess unique shape-memory properties. The 3D polymer networks allow the aligner to revert to its original printed shape after deformation.

"The biomechanical advantage of a shape-memory photopolymer is profound," noted a European orthodontic materials researcher familiar with the technology. "Unlike thermoformed plastics that warp and lose efficacy in the warm environment of the human mouth, these direct-printed resins maintain a continuous, light force. If the aligner is deformed during removal, the patient can simply expose it to warm water, and it snaps back to its programmed geometry. It changes the entire force-delivery paradigm."

Additionally, the direct-printed materials are formulated without methyl methacrylate, bisphenol A (BPA), or the photoinitiator TPO, addressing growing consumer concerns regarding the biocompatibility of long-term intraoral plastics.

An Asset-Light Blueprint for Global Scaling

While the technology is disruptive, the strategy for deploying it across Europe is equally innovative. Rather than investing hundreds of millions of euros to build massive, centralized manufacturing facilities in Europe—the traditional playbook for legacy aligner brands—Graphy is executing an "asset-light" expansion strategy.

The Seoul-based firm is positioning itself primarily as a supplier of highly specialized consumables. By partnering with established European dental companies, Graphy leverages its partners' existing production capabilities, regulatory infrastructure, and deep local distribution networks.

A prime example of this strategy in action is the strategic partnership with Smilers, the clear aligner brand of France-based Biotech Dental. Under this collaborative model, Smilers utilizes the South Korean firm's proprietary resins and manufacturing workflows to produce direct 3D-printed aligners locally in France.

This B2B model is a masterclass in modern medtech scaling. It allows the materials developer to expand its market reach rapidly without the crippling capital expenditure of building overseas factories. Meanwhile, local partners like Biotech Dental gain access to next-generation materials that allow them to differentiate their offerings in a crowded market. As production volumes at these local hubs scale up, the materials provider secures a predictable, recurring revenue stream from the ongoing supply of photopolymer resins.

Reshaping the Dental Oligopoly

The implications of this shift extend far beyond corporate balance sheets. The global dental 3D printing market, valued at roughly USD 3.7 billion in 2022, is projected to grow at a compound annual growth rate exceeding 20 percent through the end of the decade. The clear aligner segment is one of the primary engines of this growth.

For years, the clear aligner market has operated as an oligopoly, dominated by a few massive corporations that control centralized manufacturing hubs. Direct 3D printing democratizes this production. With EU-MDR compliant materials now available, mid-sized European dental laboratories and even large orthodontic clinics can theoretically bring aligner manufacturing in-house.

This localized production model drastically reduces turnaround times. What previously required shipping physical impressions or digital files across the globe and waiting weeks for a box of aligners to be shipped back can now be accomplished locally. In some clinical setups, this paves the way for "one-day orthodontics," where a patient is scanned in the morning and receives their first direct-printed aligner by the afternoon.

Furthermore, following its recent acquisition of dental imaging and hardware company RAY, Graphy is no longer just a materials supplier; it is evolving into an integrated digital dentistry ecosystem provider. By connecting diagnostic imaging, treatment planning software, 3D printing hardware, and proprietary resins, the company is offering a turnkey solution to European dental professionals.

As the ink dries on the EU-MDR certificates, the European orthodontic landscape stands on the precipice of a major transformation. The convergence of shape-memory polymers, decentralized 3D printing, and asset-light strategic partnerships is proving that the future of healthcare innovation doesn't always require building a bigger factory. Sometimes, true disruption simply requires providing the right material to the right local partners, fundamentally reshaping how the world smiles, one printed layer at a time.